Article Details
Retrieved on: 2024-10-23 17:11:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Key players, such as Sirnaomics, AiViva BioPharma, Replimune, and others, are developing drugs for NMSC. October 23, 2024 13:00 ET | Source ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here